Emotions and Mood Disorders in Chronic Diseases.

In today's society, there is an exponential increase in the diagnosis of chronic diseases due to genetic, psychological, social and environmental factors. Fortunately, the growing medical specialization makes people live longer, but at what price? This qualitative study was carried out from May 2022 to July 2022. 10 people (8 women and 2 men) aged between 18 and 70 years who were diagnosed with chronic disease were interviewed. In this study, the correlation between quality of life and the way to react to stressful events was observed. Two self-report questionnaires were administered: the Short-Form (SF-36) Health Survey to measure health status and health-related quality of life and the Coping Orientation to Problems Experienced (COPE-NVI), a tool for measuring coping styles and a semi-structured interview to assess the impact of the disease on quality of life.

Study of Dignity in Borderline Contexts: Perspectives and Critical Issues.

In 2020 Dignity Therapy Protocol was administered to the patients taken in charge by Avellino Ser. D (Addiction services of Avellino healthcare unit) for addiction problems and assigned to U.E.P.E. (Office of External Enforcement) on parole and to complete the full term of sentence. Before and after administering Dignity Therapy Protocol, Beck Depression Inventory was used in order to evaluate the possible improvement of the quality of life of the patient, associated with a decrease in depressive symptoms. This experimentation has allowed to highlight perspectives and issues in the application of Dignity Therapy Protocol, in different contexts than the one in which it was born. A decrease in the scores in the detected items has been observed in almost all participants.

A New Rating Scale (SAVE-9) to Demonstrate the Stress and Anxiety in the Healthcare Workers During the COVID-19 Viral Epidemic.

The COVID-19 epidemic has been a major global public health problem during past months in Italy and in several other Countries and on the date of publication of this article, is still a serious public health problem. The health staff, engaged in the care of the sick and in the prevention of the spread of the infection have been subjected to a further increase in psychological difficulties and work-related stress, related to the workload for the continuous influx of sick and intense and close working shifts for the viral emergency. The SAVE-9 (Stress and Anxiety to Viral Epidemics - 9 items) scale has been developed as a tool for assessing work anxiety and stress in response to the viral epidemic of health professionals working to prevent the spread of the virus and to treat infected people.

Dignity Therapy: Prevention of Suicidal Risk in the Penitentiary Area.

Dignity therapy was administered to ten prisoners in a detention center. The Beck Depression Inventory was administered before and after the intervention. The results obtained from the Beck Depression Inventory have highlighted dimensional changes in all the prisoners. There was a significant improvement in relational abilities and the disappearance of self-harming thoughts.

Neurocognitive management of the primary negative symptoms of schizophrenia: a role of atypical antipsychotics.

Patients with schizophrenia have profound and disabling cognitive deficits while negative symptoms represent a separate symptom domain, with respect to depression, neurocognition, and social cognition. Particularly, primary negative symptoms of schizophrenia represent a diagnostic and therapeutic challenge, In this study we try to evaluate the cognitive symptoms in 51 primary negative schizophrenic inpatients by the administration of simple, fast and understandable scales (MMSE, DSST, EpiTrack, PANSS cognitive factor). We also evaluate the correlation with some SGAs (aripiprazole, quetiapine, olanzapine, paliperidone). Our results support the evidence of the use of simple, rapid and acceptable scales for cognitive evaluation in clinical practice. Overall data indicate no statistically significant variations of the negative symptomatology in all the examined sample, although a reduction of the statistical averages in each group is observed (paliperidone and olanzapine, particularly).